Researchers find omega-3s generate anti-inflammatory compounds in the brain that protect cells and correlate with improved clinical outcomes.
By yourNEWS Media Newsroom
An international research team has identified a biological mechanism through which omega-3 fatty acids may reduce symptoms of major depression, demonstrating that these nutrients generate anti-inflammatory compounds in the brain that protect against cellular damage.
The findings, published in Molecular Psychiatry, show that omega-3 fatty acids—specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—are metabolized in brain cells into lipid mediators that help counter inflammation linked to depressive disorders.
Researchers used human hippocampal cells to examine how these fatty acids function at a cellular level. The hippocampus, a region associated with memory and emotional regulation, is known to be affected in depression. When exposed to inflammatory proteins, untreated cells showed increased cell death and reduced neurogenesis. Cells pretreated with EPA or DHA, however, were protected from these effects.
The study identified several lipid mediators, including HEPE, HDHA, EpETE, and EpDPA, produced when omega-3s are processed in the brain. These compounds were observed to play a direct role in reducing inflammation and supporting the formation of new neurons.
Researchers also found that these beneficial molecules are rapidly broken down in the body. Laboratory testing showed that inhibiting the enzymes responsible for this breakdown could prolong their activity, suggesting a possible pathway for future treatment development.
The laboratory findings were supported by a clinical trial involving 22 patients diagnosed with major depression. Participants received either 3 grams of EPA or 1.4 grams of DHA daily over a 12-week period. Blood analysis showed increased levels of the identified lipid mediators during supplementation.
Patients in the trial experienced measurable improvements in depressive symptoms, with average reductions of 64% in the EPA group and 71% in the DHA group. Researchers reported that higher concentrations of the lipid mediators were associated with greater symptom improvement.
The study builds on prior observations linking inflammation to depression. Individuals with depressive disorders have been shown to exhibit elevated inflammatory markers, leading researchers to investigate whether anti-inflammatory compounds could influence mental health outcomes.
By identifying a specific molecular pathway, the research provides evidence connecting dietary components to neurological processes involved in depression. The findings also suggest that therapeutic effects may require higher intake levels than those typically achieved through diet alone, indicating a potential role for supplementation under medical supervision.
“Mental health is the state of our emotional, psychological and social well-being, which influences how we think, feel and act. It is not merely the absence of mental illness, but a foundation for handling stress, relating to others and making healthy choices,” said BrightU.AI’s Enoch. “Maintaining good mental health involves proactive habits, such as managing stress and seeking support, just as we do for our physical health.”
The research highlights the interaction between diet, inflammation, and brain function, and provides a framework for further investigation into targeted treatments based on the regulation of lipid mediators.
Watch and discover the benefits of DHA-EPA Omega 3.
This video is from the Health Ranger Store channel on Brighteon.com.
Source: Natural News
Original article
Comments